Glenn M. Marshall

Cancer Institute (WIA) — India

Medicine · Health Sciences

61h-index11.7kcitations526works4.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neuroblastoma Research and Treatments(281), Protein Degradation and Inhibitors(84), Acute Lymphoblastic Leukemia research(77), Cancer, Hypoxia, and Metabolism(68), Childhood Cancer Survivors' Quality of Life(64)

Publications526 total

Abstract A002-PR011: Precision Diagnosis in High-Risk Pediatric Oncology through Integrated Whole Genome, Transcriptome, and Epigenome Profiling
Cancer Research·2025
Factors that influence the uptake of precision-guided treatment recommendations in paediatric cancer: a systematic review
British Journal of Cancer·2025Open Access
PA2G4 Functions as a Cofactor for MYC Family Oncoproteins in MYC-Driven Malignancies
Cells·2025Open Access
Establishing Research Priorities for Children Living With Chronic Health Conditions: A Value‐Weighting Study by Australian Caregivers
Journal of Paediatrics and Child Health·2025· 1 citedOpen Access
Expanding the utility of transcriptome analysis for mutation detection in high-risk childhood precision oncology
2025Open Access
Trajectory analysis reveals an uncommitted neuroblastic state in MYCN-driven neuroblastoma development
Neuro-Oncology·2025Open Access
“So what will my next cancer be?” Low-grade brain tumour diagnosed through nurse coordinated surveillance in a patient with Li Fraumeni Syndrome: A Case Report
2025Open Access
The cell-permeable iron chelator M606 inhibits MYCN-driven neuroblastoma via an E2F3-mediated response
Proceedings of the National Academy of Sciences·2025· 3 citedOpen Access
Candida auris: Patient Risk Identification in Las Vegas
American Journal of Infection Control·2025
Abstract 6863: Development of MYCN/MYC inhibitors
Cancer Research·2025
Abstract 1680: Therapeutically targeting genes and pathways activated by high-fat diet in high-risk neuroblastoma
Cancer Research·2025
Psychosocial Outcomes in Parents of Children with Acute Lymphoblastic Leukaemia in Australia and New Zealand Through and Beyond Treatment
Cancers·2025· 4 citedOpen Access
Zero Childhood Cancer: a national approach to improving outcomes of Australian children with cancer through multiomic precision medicine
Pathology·2025· 1 cited
Golgi-localized Ring Finger Protein 121 is necessary for MYCN-driven neuroblastoma tumorigenesis
Communications Biology·2024· 1 citedOpen Access
24 (PB012): Runx1t1 is an epigenetic regulator essential for MYCN-driven neuroblastoma tumorigenesis
European Journal of Cancer·2024
438 (PB426): Precision-guided treatment improves outcomes for children with highrisk cancers
European Journal of Cancer·2024
269 (PB257): Development of a precision medicine platform for paediatric acute myeloid leukaemia
European Journal of Cancer·2024
Integrated germline and somatic molecular profiling to detect cancer predisposition has a high clinical impact in poor-prognosis paediatric cancer
2024Open Access
The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis
Nature Communications·2024· 9 citedOpen Access
DIPG-48. PRECISION GUIDED THERAPY PROVIDES CLINICAL BENEFIT IN H3K27-ALTERED DIFFUSE MIDLINE GLIOMA
Neuro-Oncology·2024Open Access
page 1 of 27Next →

Frequent Co-authors

Michelle Haber(28), Murray D. Norris(26), Tao Liu(17), Belamy B. Cheung(12), Giovanni Perini(10), Toby N. Trahair(9), Pei Y. Liu(8), Andrew E. Tee(8), Chelsea Mayoh(7), Claudia L. Flemming(7), Richard B. Lock(6), David S. Ziegler(6), Daniel R. Carter(6), Jayne Murray(6), Wendy B. London(6), Bing Liu(6), Bernard Atmadibrata(6), Janice Smith(5), Susan L. Cohn(5), Giorgio Milazzo(5)